ONCOCROSS

  • Company

    • Mission

    • About Us

    • History

    • Leadership

    • Scientific Advisory Board

  • Business Areas

    • Neo Omics

    • DBB

    • Early Cancer Detection & Monitoring

    • Collaboration

  • Technology Platform

    • RAPTOR AI® VERSION 2.0

    • ONCOfind AI ®

  • Pipeline

  • News/IR

    • Notice

    • Press Releases

    • IR Materials

    • Knowledge Hub

    • Latest Cancer Information

    • Disclosure Information

    • Stock Information

  • OncoMaster

CONTACT US
  • KR
  • EN
  • Company

    • Mission

    • About Us

    • History

    • Leadership

    • Scientific Advisory Board

  • Business Areas

    • Neo Omics

    • DBB

    • Early Cancer Detection & Monitoring

    • Collaboration

  • Technology Platform

    • RAPTOR AI® VERSION 2.0

    • ONCOfind AI ®

  • Pipeline

  • News/IR

    • Notice

    • Press Releases

    • IR Materials

    • Knowledge Hub

    • Latest Cancer Information

    • Disclosure Information

    • Stock Information

  • OncoMaster

  • KR
  • EN
CONTACT US
  • Main
  • News/IR
  • Press Releases

Press Releases

181 Posts
  • 바이오스펙테이터

    에이치엘비생과, AI 온코크로스와 항암제 개발 MOU

    04-12-2021
  • 한국경제

    에이치엘비생명과학, AI 신약기업 온코크로스와 양해각서 체결

    04-12-2021
  • 헬로디디

    충남대병원·온코크로스 "AI로 신약개발 속도낸다"

    04-11-2021
  • 메디컬투데이

    충남대병원-온코크로스, AI 신약개발 공동연구 업무협약

    04-09-2021
  • 메디게이트뉴스

    온코크로스, 분당차병원과 상호 협력을 위한 양해각서 체결

    04-09-2021
  • 머니투데이

    온코크로스, 분당차병원과 상호 협력 위한 양해각서 체결

    04-08-2021
  • 머니투데이

    온코크로스, 삼성서울병원과 연구협력협약 체결

    04-02-2021
  • Korea Biomedical Review

    AI startups team up with drugmakers for drug repurposing

    04-02-2021
  • 메디게이트뉴스

    AI신약 벤처 온코크로스, 삼성서울병원과 연구협력협약서 체결

    04-02-2021
  • Merger Market

    Korean AI drug developer secures $14m Series B

    04-02-2021
  • 세계비즈

    제약업계, AI활용 신약개발 '대세'…“비용·시간 줄인다”

    03-31-2021
  • 머니투데이

    'AI신약' 온코크로스, 대웅제약과 공동연구·투자유치 계약

    03-23-2021
  • «
  • ‹
  • 11
  • 12
  • 13
  • 14
  • 15
  • ›
  • »

Please enter a prompt

ONCOCROSS
CEO
Yi Rang KIM / Jihoon KANG
Address
Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)
Tel
02-717-9967
Fax
02-867-9968
Email
oncocross@oncocross.com
Terms & Conditions Privacy Policy Cookie Policy
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.